Citigroup Inc Bausch Health Companies Inc. Call Options Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	BUY	$6.28 - $9.85 $1.77 Million - $2.78 Million	282,300 New	282,300 $2.29 Million
Q3 2022 Nov 10, 2022	BUY	$4.58 - $9.21 $9.64 Million - $19.4 Million	2,104,000 New	2,104,000 $14.6 Million
Q1 2022 May 12, 2022	SELL	$21.6 - $27.79 $8.2 Million - $10.6 Million	-379,700 Reduced 86.32%	60,200 $1.38 Million
Q4 2021 Feb 10, 2022	BUY	$23.0 - $29.01 $5.39 Million - $6.8 Million	234,300 Added 113.96%	439,900 $12.2 Million
Q3 2021 Nov 10, 2021	BUY	$25.04 - $30.06 $5.15 Million - $6.18 Million	205,600 New	205,600 $5.73 Million

254

254M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.63B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.